Future perspectives in the treatment of acute lymphoblastic leukemia

Dieter Hoelzer

At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.

Share this video  
Acute Lymphoblastic Leukemia
EHA 2015
12th June 2015
More from Dieter Hoelzer
New aims and next steps for adult ALL induction therapy
Two important therapies for ALL
Exploring the potential of T-cell therapy for acute lymphoblastic leukemia
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals